title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.
authors.forename: Naoki
authors.initials: N
authors.lastname: Goto
authors.forename: Reiji
authors.initials: R
authors.lastname: Yoshimura
authors.forename: Junji
authors.initials: J
authors.lastname: Moriya
authors.forename: Shingo
authors.initials: S
authors.lastname: Kakeda
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Ueda
authors.forename: Atsuko
authors.initials: A
authors.lastname: Ikenouchi-Sugita
authors.forename: Wakako
authors.initials: W
authors.lastname: Umene-Nakano
authors.forename: Kenji
authors.initials: K
authors.lastname: Hayashi
authors.forename: Norihiro
authors.initials: N
authors.lastname: Oonari
authors.forename: Yukunori
authors.initials: Y
authors.lastname: Korogi
authors.forename: Jun
authors.initials: J
authors.lastname: Nakamura
mesh_terms: D000328:Adult; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D003401:Creatine / Q000378:metabolism; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008297:Male; D011522:Protons; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000378:metabolism / Q000473:pathology*; D055815:Young Adult; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D011522:Protons; D005680:gamma-Aminobutyric Acid; D003401:Creatine